Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Forecast Highlights Expansion From $1.79 Billion To $3.43 Billion Through 2030
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Forecast Highlighting Growth From $1.79 Billion To $3.43 Billion
The market size for arrayed clustered regularly interspaced short palindromic repeats (crispr) screening has experienced rapid expansion in recent years. It is projected to expand from $1.52 billion in 2025 to $1.79 billion in 2026, achieving a compound annual growth rate (CAGR) of 17.5%. This historical growth can be attributed to the broadening of functional genomics research, the availability of crispr editing reagents, the rise of academic screening programs, the early adoption of arrayed screening formats, and the increasing utilization of cell-based assays.
The crispr screening market is projected to experience substantial expansion over the upcoming years. By 2030, this market is anticipated to reach a valuation of $3.43 billion, growing at a compound annual rate of 17.7%. This anticipated growth during the forecast period is fueled by several factors, including the rising need for precision drug discovery, increased funding for gene therapy research, the broadening scope of disease modeling applications, the expanding adoption of bioinformatics-powered screening methods, and strengthened partnerships between academic institutions and industrial sectors. Key trends defining this period encompass a heightened demand for targeted gene validation screens, the increased implementation of high-throughput arrayed crispr assays, the deeper integration of phenotypic data analytics, the broader availability of customized crispr screening solutions, and an intensified emphasis on precision in functional genomics.
Download A Free Sample Report For Comprehensive Market Insights:
Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Demand Drivers: What Is Fueling Industry Growth?
The growing emphasis on personalized medicine is anticipated to boost the arrayed clustered regularly interspaced short palindromic repeats (CRISPR) screening market in the coming years. Personalized medicine, a medical strategy, customizes patient treatment and prevention plans based on their unique genetic, biological, and lifestyle attributes. Its increasing adoption stems from advancements in genomics and molecular diagnostics, enabling the creation of treatments precisely suited to an individual’s genetic makeup for enhanced results. Arrayed CRISPR screening plays a crucial role in personalized medicine by systematically evaluating how specific gene modifications impact individual cellular responses. This capability allows for the identification of drug targets specific to patients, forecasting treatment outcomes, and designing personalized therapies tailored to a person’s genetic and cellular profile. As an illustration, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 new personalized treatments for rare disease patients in 2023, a notable increase from six in 2022. Among the newly approved personalized treatments for 2023 were also seven cancer drugs and three for other diseases and conditions. Consequently, the heightened focus on personalized medicine is propelling the growth of the arrayed clustered regularly interspaced short palindromic repeats (CRISPR) screening market.
Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Segmentation: How Is The Market Structured Across Key Categories?
The arrayed clustered regularly interspaced short palindromic repeats (crispr) screening market covered in this report is segmented –
1) By Product Type: Clustered Regularly Interspaced Short Palindromic Repeats Libraries; Reagents And Consumables; Instruments; Software And Services
2) By Application: Functional Genomics; Drug Discovery; Disease Modeling; Gene Validation; Other Applications
3) By End User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Contract Research Organizations; Other End Users
Subsegments:
1) By Clustered Regularly Interspaced Short Palindromic Repeats Libraries: Genome Wide Knockout Libraries; Targeted Gene Libraries; Activation Libraries; Repression Libraries; Custom Designed Libraries
2) By Reagents And Consumables: Guide Ribonucleic Acid Reagents; Cas Enzyme Reagents; Transfection Reagents; Cell Culture Reagents; Assay And Detection Reagents
3) By Instruments: Automated Liquid Handling Systems; High Throughput Screening Systems; Cell Imaging Systems; Flow Cytometry Instruments; Genomic Analysis Instruments
4) By Software And Services: Screening Design Software; Data Analysis Software; Bioinformatics Services; Screening Execution Services; Custom Assay Development Services
Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Innovation Trends: Which Developments Are Transforming The Industry?
Leading companies in the arrayed clustered regularly interspaced short palindromic repeats (CRISPR) screening market are increasingly adopting strategic partnerships to enhance the precision of high-throughput phenotypic screening. A strategic partnership involves formal collaboration where organizations pool resources, knowledge, or technologies to achieve common goals, fostering quicker innovation, reducing risk, and broadening market reach without necessitating a merger or acquisition. For instance, in November 2023, AstraZeneca Plc, a UK-based science-led biopharmaceutical company, established a partnership with the Medical Research Council (MRC), a UK-based government agency, and the Milner Therapeutics Institute (MTI) at the University of Cambridge, a UK-based biomedical research institute, to launch the Functional Genomics Screening Laboratory (FGSL), a cutting-edge facility aimed at advancing drug discovery. This laboratory is designed to map gene-phenotype relationships in chronic conditions, including cardiovascular and metabolic disorders, thereby advancing UK genomics leadership through open academic collaborations. Its advantages feature high-throughput automation for precise imaging and phenotyping in organoids or iPSCs, which surpasses pooled methods; benefits also include free access for researchers, accelerated target validation, and shared expertise to expedite the development of therapies.
Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Competitive Landscape And Leading Companies
Major companies operating in the arrayed clustered regularly interspaced short palindromic repeats (crispr) screening market are Thermo Fisher Scientific Inc, Merck KGaA, GE HealthCare Technologies Inc, Applied Biological Materials Inc, Agilent Technologies Inc, Charles River Laboratories International Inc, Integrated DNA Technologies Inc, GenScript Biotech Corporation, Synthego Holdings LLC, Santa Cruz Biotechnology Inc, Creative Biolabs Inc, VectorBuilder Inc, Admera Health LLC, Addgene Inc, Ncardia, BioCat GmbH, Cellecta Inc, GeneCopoeia Inc, Creative Biogene Inc, and Aelian Biotechnology.
Access The Complete Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Report:
Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the arrayed clustered regularly interspaced short palindromic repeats (CRISPR) screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the arrayed clustered regularly interspaced short palindromic repeats (crispr) screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
